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Abstract
In 2008 at least five complete genome sequences are 
available. It is known that there are over 15,000,000 ge-
netic variants, called SNPs, in the dbSNP database. The 
cost of full genome sequencing in 2009 is claimed to be 
less than $5000 USD. The genomics era has arrived in 
2008. This review introduces technologies, bio-
informatics, genomics visions, and variomics projects. 
Variomics is the study of the total genetic variation in an 
individual and populations. Research on genetic varia-
tion is the most valuable among many genomics re-
search branches. Genomics and variomics projects will 
change biology and the society so dramatically that bi-
ology will become an everyday technology like personal 
computers and the internet. 'BioRevolution' is the term 
that can adequately describe this change.
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Introduction
Since the launch of the Human Genome Project (HGP) 
in 1990 by NIH of USA, researchers have been develop-
ing faster DNA sequencers (Chan, 2005; Gupta, 2008; 
Mardis, 2008; Metzker, 2005; Shendure et al., 2004). 
HGP has been said to be led by James Watson who 
modeled DNA in Cambridge, UK in 1953. In 2003, the 
International Human Genome Sequencing Consortium 
held a press conference to announce the completion of 
the human genome (IHGSC, 2004). In 2008, after 55 
years, Watson’s complete genome sequence was publi-
cized by using 454 DNA sequencers developed by a 
company rather than a research institute (Wheeler et al., 
2008). In 2007, Craig Venter, a former Celera founder, 
published his own personal genome in PLoS Biology 
(Levy et al., 2007). We are entering the personalized bi-
ology era with the advent of next generation sequencing 
technologies.
DNA Sequencing
The first breakthrough in genome sequencing came from 
Watson's colleague, Fred Sanger, in Cambridge, UK. In 
1977, Sanger and his team produced the first useful 
DNA sequencing method and publicized the first com-
plete genome (Sanger et al., 1977). It was a tiny virus 
genome known as phi X 174. Soon after phi X 174, he 
published the first complete organelle genome which 
was a mitochondrion (Anderson et al., 1981). By 1998, 
researchers in the US evaluated multiplex genome se-
quencing technologies and were aware that one per-
son's whole genome could be sequenced in a day using 
contemporary technologies. George Church was a Ph.D. 
student of Walter Gilbert who received a Nobel Prize 
with Sanger for developing a sequencing method. 
Gilbert's method was not widely used. However, his col-
league Church continued to develop sequencing 
methods. One of them is based on the Polony idea 
(Porreca et al., 2006). This technology is used by 
KNOME Inc., a full genome sequencing company. Along 
with KNOME, other companies, such as Complete 
Genomics, are now producing DNA sequences cheaply 
and in an unprecedented capacity. The speed of se-
quencing is advancing many folds per year, much faster 
than the cycle of semiconductor chips in computer 
industries. Also, genome sequencing technology is be-
coming an everyday technology at the level as com-
puter CPUs are universally used. In five years’ time, ex-
perts predict that everyone in developed nations will be 
able to have his or her own genome information. Due to 
its far reaching consequences in medicine, health, biol-
ogy, nanotechnology, and information technology, DNA 
sequencing will become the most important industrial 
technology ever developed during the next decades.
Personal Genomics
In 2009, genome sequencing technologies will achieve 
one person's whole genome per day in terms of DNA 
fragments sequenced. Personal genomics is a new term 
that utilizes such fast sequencers. In 2008, the cost for 
one personal genome is less than $350,000 USD. If the 
cost goes down below $1,000 USD, the impact of per-
sonal genomics is predicted to be the largest ever in bi-
ology in common people's lives. Reflecting this techno-
logical advancement to society is the PGP (Personal 
Genome Project), a project to sequence as many people 
as possible with lowest possible cost (Church, 2005). At 
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present, Google, Inc. and the Church group are working 
together to sequence 100,000 people’s genetic regions 
of DNA. In Saudi Arabia, the government is planning to 
sequence 100 Arabic people’s genome. In Europe, there 
are various groups of people and nations who have 
been genotyping those populations. Iceland has been 
especially successful in that effort by utilizing their 
well-kept genealogical data encompassing hundreds of 
thousands of people. In Asia, Jeongsun Seo of Seoul 
National University has been working on the East Asia 
Genome Project during the past several years. His 
group has collected thousands of samples from 
Mongolian tribes with a extremely large genealogical 
tree among them (Park et al., 2008; Sung et al., 2008). 
Seo is said to be sequencing at least 100 Korean ge-
nomes in collaboration with Church and Green Cross, 
Inc. of Korea. The aim of Seo’s genome project is to 
produce a resource for East Asians. He is presently se-
quencing at least two Korean people. In China, Beijing 
Genome Institute has been successful in terms of 
sequencing. Their first achievement came from a plant 
genome, rice. After rice, they launched a 100 Han 
Chinese genome sequencing project. In Nov. 2008, they 
published their first Chinese genome in a journal, 
Nature. In Dec. 2008, another Korean group, Lee Gilyeo 
Cancer and Diabetes Institute (LCDI) and Korean 
Bioinformation Center (KOBIC) made a Korean genome 
sequence public. The genome was sequenced by 
Solexa paired-end sequencer, and comparative ge-
nomics analyses and SNP data were uploaded as a 
public resource. It took only one week to analyze the 
7.8x Korean genome using 150 computer CPUs to pro-
duce mapping DNA fragments to a reference genome, 
generate new SNP information, compare that with other 
individual genomes, and map it with 1600 already 
known phenotype information from the public literature.
Genome Revolution
These public genome data alongside previously known 
Craig Venter's and James Watson's mark that full ge-
nome sequences are not soley in academic domain 
anymore. Anyone who has money and the will can se-
quence human genomes. This 'genomic revolution' will 
eventually lead to the 'BioRevolution' in terms of making 
the most essential human information completely map-
ped and publically available. This is revolutionary, be-
cause humans can now engineer themselves with a 
map or a blue print not directly relying on trial and error 
style conventional evolutionary methods. This indicates 
that evolution has moved to a conscious level driving 
evolution. We are in effect designing evolution using 
computers.
Genomes and Personalized Medicine
The consequences of 'BioRevolution' where genomic in-
formation is utilized by scientists to engineers all kinds 
of biological processes, including evolution itself, will 
bring us personalized medicine. The essence of person-
alized medicine is that enzymes in our tissues, such as 
cytochrome P450, have distinct differences among in-
dividuals and populations. Certain drugs produce differ-
ent responses in individuals.
Cytochrome p450 Family Example
The cytochrome P450 (CYP) family of liver enzymes is 
responsible for breaking down more than 30 different 
classes of drugs during Phase I of drug metabolism. 
Structural and SNP variations of the genes that code for 
these enzymes can influence their ability to metabolize 
certain drugs. Based upon this, a population can be 
categorized into four major types of drug metabolizers: 
  ∙ Extensive metabolizers: Individuals that can be ad-
ministered with normal drug dosage 
  ∙ Intermediate metabolizers: Individuals that metabo-
lize drugs with a slower than normal rate. 
  ∙ Poor metabolizers: Individuals with poor metaboliz-
ing rates. Drugs may accumulate and cause serious 
adverse effects. 
  ∙ Ultra metabolizers: Individuals with metabolizing 
rates even faster than extensive metabolizers. They 
may experience no effect of drug activity. 
  In early 2005, the US FDA cleared the AmpliChipⓇ 
CYP450 Test, which measures variations in two genes 
of the CYP450 enzyme system: CYP2D6 and CYP2C19. 
The Roche AmpliChip CYP450 Test is intended to iden-
tify a patient's CYP2D6 and CYP2C19 genotype from 
genomic DNA extracted from a whole blood sample. 
Information about CYP2D6 and CYP2C19 genotype may 
be used as an aid to clinicians in determining ther-
apeutic strategy and treatment dose for therapeutics 
that are metabolized by the CYP2D6 or CYP2C19 gene 
product.
Variomics
The most important scientific data out of personal ge-
nomes are the precise sequence differences among 
individuals. Such differences have many types. There 
are structural differences among chromosomes. There 
can be insertions and deletions of DNA segments. There 
are certain fragments that appear as repeats in genom-
es. Mapping all these structural genetic variations can 
be briefly termed 'variomics'. A variome is the totality of 
genetic variation found in an individual, a population, 
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and a species. Among all the variations we know, the 
most common is the single nucleotide polymorphisms 
(SNP). In Korea, mapping the variome has been pursued 
relatively early, and there are several groups who are 
mapping the genetic variations. KOBIC has several very 
early stage, if not the earliest in the world, variome serv-
ers: http://variome.net and http://variomics.net. Along 
with SNP variation, the copy number variation (CNV) is 
also important. Some recent reports tell us that CNVs 
can be as variable as or even more variable than SNPs 
that are simple DNA base changes in populations. 
Yeun-Jun Chung of the Catholic University of Korea has 
been mapping CNVs among Korean people (Kim et al., 
2008).
Human Variome Project (HVP)
As an international collaboration, headed by Richard Cotton, 
HVP was launched in 2006 (http://humanvariomeproject. 
org) (Ring et al., 2006). HVP aims to make clinicians 
who have been working on rare diseases, to work to-
gether with molecular biologists and bioinformaticians. 
Their goal is to link medical information with genotype 
information. Succinctly, this process is called genotype 
to phenotype mapping. As several full human genome 
sequences are already available, mapping phenotypes 
to full genomes will be the major challenge of biology 
in the next 20 years.
Asian Variome Project (AVP)
Alongside and with the associations of eIMBL, A-IMBN, 
and HVP, a variome project that is working to map the 
Asian population variome was launched in 2008. This 
was a group effort by Korean researchers who have 
been interested in genome sequences, SNPs, and 
CNVs. They have formed the KOrean VAriome Consor-
tium (KOVAC: http://variome.kr) and support AVP as one 
of the first projects. eIMBL, the virtual laboratory net-
work of Asia linking key biology groups modeled after 
EMBL, has acquired $80,000 USD in 2008 to support 
AVP. eIMBL aims to establish a virtual bioinformatics 
center in the Asia Pacific region that will link many bio-
information processing scientists in Asia.
Construction of Reference Genomes for 
the World
Sanger Center, EBI, NCBI, and the University of Wa-
shington Genome Center have formed a consortium to 
produce a reference genome (http://referencegenome.org). 
A reference standard is the most important standard 
among all the standards. Providing an accurate refer-
ence genome to biologists is an important task. The first 
reference genome by the above consortium is based on 
Caucasian genomes. Due to the extent of SNPs and 
CNVs, it is necessary to construct reference genomes 
for diverse ethnic groups. In Korea, since 2006, the ref-
erence standard genome project began and produced 
the first draft for Koreans in November, 2008, using a 
male donor. Through the bioinformatic analysis, the 
Korean researchers in LCDI and KOBIC found that there 
was a good justification for any nation to launch large 
scale genome projects to map population diversities. 
Even such close populations as Korean and the Chinese 
showed a large quantity of SNP differences.
Bioinformatics for Personal Genomes 
and Variomes
Bioinformatics is the key in personal genome projects 
and variome projects. Bioinformatics is not merely a set 
of tools but a scientific discipline. It regards life as a gi-
gantic information processing phenomenon and works 
to map its components and to model the emerging net-
works of the components. Bioinformatics in 2008 is driv-
ing biology into an information science. Most biology re-
search projects produce massive amounts of data that 
cannot be processed by hand. Nearly all biological re-
search outcomes in the next five years will have some 
form of high throughput data such as genome se-
quences, microarray data, proteome analyses, SNPs, 
epigenome chips, and large scale phenotype mapping. 
Bioinformatics tools in genomics and variomics can be 
found from various internet resources. There are several 
bioinformatics hubs such as NCBI (National Center for 
Biotechnology Information), EBI (European Bioinforma-
tics Institute), DDBJ (Databank of Japan), and KOBIC. 
Some others are: Bioinformatics Organization (http:// 
Bioinformatics.Org), EMBnet (http://www.embnet.org/), 
and The International Society for Computational Biology 
(http://iscb.org). 
  The following are major bioinformatics journals:
  ∙ Algorithms in Molecular Biology (http://www.almob. 
org/) 
  ∙ Bioinformatics (http://bioinformatics.oxfordjournals.org/)
  ∙ BMC Bioinformatics (http://www.biomedcentral.com/ 
bmcbioinformatics) 
  ∙ Briefings in Bioinformatics (http://bib.oxfordjournals. 
org/) 
  ∙ Genome Research (http://genome.cshlp.org/) 
  ∙ Genomics and Informatics (http://www.genominf-
o.org) 
  ∙ The International Journal of Biostatistics (http:// 
www.bepress.com/ijb/) 
  ∙ Journal of Computational Biology (http://www. 
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liebertpub.com/Products/Product.aspx?pid=31&Asp
xAutoDetectCookieSupport=1) 
  ∙ Cancer Informatics (http://www.la-press.com/journal. 
php?pa=description&journal_id=10) 
  ∙ Molecular Systems Biology (http://www.nature.com/ 
msb/index.html 
  ∙ PLoS Computational Biology (http://www.ploscompbiol. 
org/home.action) 
  ∙ International Journal of Bioinformatics Research 
and Applications (http://www.inderscience.com/browse/ 
index.php?journalcode=ijbra) 
Sequencing DNA, Metagenomics, and 
Ecogenomics
Next generation sequencing methods will not only map 
genomes. They will be used to map the environment. 
This is called ecogenomics. To humans the environment 
can mean various microbial, plant, and animal inter-
actions around us. Microbial interaction is especially 
critical to our health. Gut bacteria are a natural environ-
ment within us. Metagenomics is a methodology that 
sequences the whole set of microbes in our food tract. 
Researchers are realizing that the human genome is 
complemented by such environmental genomes. A new 
term, 'ecogenomics' is now used to describe these 
concepts. Metagenomics and ecogenomics are for map-
ping the variations of environmental genetic factors.
Mapping Expression using DNA Se-
quencing
DNA sequencing technologies were mostly used for 
mapping genotypes. However, they are now used to 
map RNA expression levels in cells. Cells produce vari-
ous types of RNA. mRNA is the most abundant and 
important. In the past, microarray and DNA chips were 
used to measure expression levels. They are not accu-
rate and take many bioinformatic adjustments before 
producing reliable expression data. New sequencing 
technologies can measure expression levels much more 
accurately. By sequencing the RNAs, we can now quan-
tify the expression levels by precisely knowing the RNA 
sequences. Sequencing technologies will restructure the 
expression analyses in the future.
Linking Genome Information On-line 
Sequencing a genome is basically the production of da-
ta, whereas analyzing the whole genome takes human 
minds networking their hypotheses, proofs, and discov-
eries, i.e. genomics is a scientific endeavor beyond me-
chanical sequencing. Therefore, a worldwide effort is re-
quired to link all the genome information for proper 
management and utilization. The internet is the best in-
frastructure for genome information exchange. Bioinfor-
matics resources should be available as freely as possi-
ble for all nations, including those underdeveloped and 
developing. Genome sequencing and associated analy-
ses should be done freely in certain instances by the 
support of local governments and international organi-
zations. For maximum efficiency, an adequate data and 
information license should also be required. Some re-
searchers propose an openfree sharing of bioinformatics 
analysis tools, as well as the genome sequences (under 
proper permission). One such movement is Free Geno-
mics (http://freegenomics.org).
  The following are on-line genomics sites:
  ∙ Genomics portal: http://genomics.org
  ∙ Personal Genome Project: http://personalgenomes.org
  ∙ openfree Genomics Project: http://personalgenome. 
net
  ∙ Personal Genome sequencing company: http://www. 
knome.com
  ∙ Personal Genome SNP typing: http://decodeme. 
com
  ∙ Google’s Personal Genome Typing: http://23andme. 
com
  ∙ The Sanger Centre: http://sanger.ac.uk
  ∙ General Omics site: http://omics.org
  ∙ Korean Genome Data Site: http://koreagenome.org
  ∙ Korean Bioinformation Center: http://kobic.kr
Conclusion
We have examined the current trends in genomics and 
variomics. In 2009 and onwards, personal genome proj-
ects will produce an unprecedented amount of bio-
logical data. New bioinformatics technologies will be re-
quired to handle them. New sequencing technologies 
will drive the next decades of biology and transform 
medical practices. Fast sequencing brought us interest-
ing and unexpected applications such as metagenomics 
and ecogenomics. 
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